380 related articles for article (PubMed ID: 33003204)
1. Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma.
Li Y; Gu J; Xu F; Zhu Q; Chen Y; Ge D; Lu C
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33003204
[TBL] [Abstract][Full Text] [Related]
2. Link between m6A modification and infiltration characterization of tumor microenvironment in lung adenocarcinoma.
Yang S; Li K; Zhang J; Liu J; Liu L; Tan Y; Xu C
Exp Biol Med (Maywood); 2023 Dec; 248(23):2273-2288. PubMed ID: 38166412
[TBL] [Abstract][Full Text] [Related]
3. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
Zhao W; Xie Y
Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
[TBL] [Abstract][Full Text] [Related]
4. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
[TBL] [Abstract][Full Text] [Related]
5. [Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
Ke J; Cui J; Yang X; Du X; Ma B; Yu L
Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):311-322. PubMed ID: 35599007
[TBL] [Abstract][Full Text] [Related]
6. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
Ye W; Huang T
PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis Revealed the Potential Implications of m6A Regulators in Lung Adenocarcinoma.
Xie L; Dai R; Wang X; Xie G; Gao Z; Xu X
Front Mol Biosci; 2022; 9():806780. PubMed ID: 35419413
[No Abstract] [Full Text] [Related]
8. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
9. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.
Liu X; Ma C; Liu H; Sun Z; Luo J
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010
[TBL] [Abstract][Full Text] [Related]
10. Effects of N6-Methyladenosine Regulators on LAG3 and Immune Infiltrates in Lung Adenocarcinoma.
Wang N; Xu Y; Jin L; Wang X; Wu S; Wang Y; Zhao J; Zhou F; Ge H
Dis Markers; 2022; 2022():1829528. PubMed ID: 36051357
[TBL] [Abstract][Full Text] [Related]
11. Characterization of m
Zhu M; Cui Y; Mo Q; Zhang J; Zhao T; Xu Y; Wu Z; Sun D; Zhang X; Li Y; You Q
Front Immunol; 2021; 12():782551. PubMed ID: 34975871
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
13. A Novel m6A-Related LncRNA Signature for Predicting Prognosis, Chemotherapy and Immunotherapy Response in Patients with Lung Adenocarcinoma.
Shen Y; Wang S; Wu Y
Cells; 2022 Aug; 11(15):. PubMed ID: 35954243
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma.
Tian L; Wang Y; Tian J; Song W; Li L; Che G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493
[TBL] [Abstract][Full Text] [Related]
15. N6-methyladenosine (m6A) regulator expression pattern correlates with the immune landscape in lung adenocarcinoma.
Wan RJ; Bai L; Jiang J; Hu CP; Chen Q; Zhao BR; Zhang Y; Li YY
Gene; 2022 Aug; 836():146639. PubMed ID: 35700805
[TBL] [Abstract][Full Text] [Related]
16. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma.
Ji J; Liu S; Liang Y; Zheng G
BMC Genom Data; 2023 Aug; 24(1):44. PubMed ID: 37568073
[TBL] [Abstract][Full Text] [Related]
18. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
Front Immunol; 2021; 12():723172. PubMed ID: 34539658
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of Clinical Significance, Immune Infiltration and Biological Role of m
Zhou B; Gao S
Front Immunol; 2021; 12():698236. PubMed ID: 34650549
[TBL] [Abstract][Full Text] [Related]
20. A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma.
Wang X; Zhao C; Huang D; Liu Z; Liu M; Lin F; Lu Y; Jia J; Lin L; Lin X; Li H; Chen Z
Front Immunol; 2022; 13():923533. PubMed ID: 35860262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]